Briefing
ctDNA in stage I, II, and III germ cell tumors
Diagnostic study collecting serial ctDNA in high-risk stage I, stage II, and stage III germ cell tumors to estimate positive predictive value for relapse, retroperitoneal histology, and progression after chemotherapy.
- Design: Not applicable · Recruiting